BFM
GOSS icon

Boothbay Fund Management’s Gossamer Bio GOSS Stock Holding History

Boothbay Fund Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-729
Closed -$53.2K – 1709
2023
Q4 		$53.2K Buy
+729
New +$43.1K ﹤0.01% 1517
2022
Q4 		– Sell
-1,082
Closed -$1.04M – 2165
2022
Q3 		$1.04M Sell
1,082
-205
-16% -$204K 0.03% 851
2022
Q2 		$862K Buy
1,287
+381
+42% +$236K 0.02% 888
2022
Q1 		$629K Sell
906
-549
-38% -$424K 0.01% 1173
2021
Q4 		$1.32M Sell
1,455
-221
-13% -$210K 0.03% 636
2021
Q3 		$1.69M Buy
1,676
+393
+31% +$289K 0.05% 517
2021
Q2 		$833K Buy
1,283
+27
+2% +$18.7K 0.03% 783
2021
Q1 		$929K Hold
1,256
– – 0.03% 635
2020
Q4 		$971K Buy
1,256
+643
+105% +$507K 0.04% 503
2020
Q3 		$608K Sell
613
-134
-18% -$142K 0.04% 594
2020
Q2 		$776K Buy
+747
New +$752K 0.05% 456
2019
Q2 		– Sell
-163
Closed -$282K – 794
2019
Q1 		$282K Buy
+163
New +$272K 0.03% 519

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Boothbay Fund Management's GOSS Position: Q1 2024 in Review

Boothbay Fund Management sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 729 shares — an estimated $53.2K sold.

Boothbay Fund Management first reported a position in GOSS in Q1 2019 and held it in 12 quarters. The position peaked at $1.69M in Q3 2021. 108 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • Boothbay Fund Management reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 729 Gossamer Bio shares in Q1 2024, an estimated $53.2K.
  • Boothbay Fund Management first reported a position in Gossamer Bio in Q1 2019 and held it in 12 quarters.
  • Boothbay Fund Management's Gossamer Bio position peaked at $1.69M in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.